HKMPY Hikma Pharmaceuticals PLC ADR

USD 58.78 +1.12 ( +1.94%)
Icon

Hikma Pharmaceuticals PLC ADR (HKMPY) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 58.78

+1.12 (+1.94%)

USD 6.38B

300.00

N/A

N/A

Icon

HKMPY

Hikma Pharmaceuticals PLC ADR (USD)
COMMON STOCK | OTC
USD 58.78
+1.12 ( +1.94%)
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 6.38B

N/A

USD 58.78

Hikma Pharmaceuticals PLC ADR (HKMPY) Stock Forecast

N/A

Based on the Hikma Pharmaceuticals PLC ADR stock forecast from 0 analysts, the average analyst target price for Hikma Pharmaceuticals PLC ADR is not available over the next 12 months. Hikma Pharmaceuticals PLC ADR’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Hikma Pharmaceuticals PLC ADR is Neutral, which is based on 7 positive signals and 8 negative signals. At the last closing, Hikma Pharmaceuticals PLC ADR’s stock price was USD 58.78. Hikma Pharmaceuticals PLC ADR’s stock price has changed by +2.26% over the past week, +16.28% over the past month and +17.77% over the last year.

No recent analyst target price found for Hikma Pharmaceuticals PLC ADR
No recent average analyst rating found for Hikma Pharmaceuticals PLC ADR

Company Overview Hikma Pharmaceuticals PLC ADR

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primaril...Read More

https://www.hikma.com

1 New Burlington Place, London, United Kingdom, W1S 2HR

9,100

December

USD

USA

Adjusted Closing Price for Hikma Pharmaceuticals PLC ADR (HKMPY)

Loading...

Unadjusted Closing Price for Hikma Pharmaceuticals PLC ADR (HKMPY)

Loading...

Share Trading Volume for Hikma Pharmaceuticals PLC ADR Shares

Loading...

Compare Performance of Hikma Pharmaceuticals PLC ADR Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for HKMPY

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Hikma Pharmaceuticals PLC ADR (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MKGAF
MERCK Kommanditgesellschaft au.. -5.80 (-4.05%) USD68.66B 23.76 12.37

Frequently Asked Questions About Hikma Pharmaceuticals PLC ADR (HKMPY) Stock

Stock Target Advisor's fundamental analysis for Hikma Pharmaceuticals PLC ADR's stock is Neutral.

HKMPY stock's dividend yield is 2.75%. Our analysis grades HKMPY stock's dividend yield at C-. This means that HKMPY stock's dividend yield is above 70% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange. Based on this HKMPY may be a average dividend stock for its sector.

Unfortunately we do not have enough data on HKMPY's stock to indicate what its average analyst target is.

HKMPY stock's Price/Earning ratio is 33.81. Our analysis grades HKMPY stock's Price / Earning ratio at F. This means that HKMPY stock's Price/Earning ratio is above 81% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange. Based on this HKMPY may be a overvalued for its sector.

The last closing price of HKMPY's stock was USD 58.78.

The most recent market capitalization for HKMPY is USD 6.38B.

Unfortunately we do not have enough analyst data on HKMPY's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Hikma Pharmaceuticals PLC ADR's stock.

As per our most recent records Hikma Pharmaceuticals PLC ADR has 9,100 Employees.

Hikma Pharmaceuticals PLC ADR's registered address is 1 New Burlington Place, London, United Kingdom, W1S 2HR. You can get more information about it from Hikma Pharmaceuticals PLC ADR's website at https://www.hikma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Hikma Pharmaceuticals PLC ADR (HKMPY) Stock

Stock Target Advisor's fundamental analysis for Hikma Pharmaceuticals PLC ADR's stock is Neutral.

HKMPY stock's dividend yield is 2.75%. Our analysis grades HKMPY stock's dividend yield at C-. This means that HKMPY stock's dividend yield is above 70% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange. Based on this HKMPY may be a average dividend stock for its sector.

Unfortunately we do not have enough data on HKMPY's stock to indicate what its average analyst target is.

HKMPY stock's Price/Earning ratio is 33.81. Our analysis grades HKMPY stock's Price / Earning ratio at F. This means that HKMPY stock's Price/Earning ratio is above 81% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange. Based on this HKMPY may be a overvalued for its sector.

The last closing price of HKMPY's stock was USD 58.78.

The most recent market capitalization for HKMPY is USD 6.38B.

Unfortunately we do not have enough analyst data on HKMPY's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Hikma Pharmaceuticals PLC ADR's stock.

As per our most recent records Hikma Pharmaceuticals PLC ADR has 9,100 Employees.

Hikma Pharmaceuticals PLC ADR's registered address is 1 New Burlington Place, London, United Kingdom, W1S 2HR. You can get more information about it from Hikma Pharmaceuticals PLC ADR's website at https://www.hikma.com.
Loading...